Harrods Becomes UK Gateway for Shinsegae-Owned Swiss Perfection
Swiss Perfection's exclusive Harrods launch shows how Shinsegae is using single-retailer partnerships to convert a spa-only brand into a consumer skincare name.
obsuo.
Beauty industry news and analysis, with sources cited.
Lubrizol's New Thickener Tackles the Hardest Problem in Sulfate-Free Formulation
Glucamate Evolve is built to solve a persistent manufacturing headache: sulfate-free surfactant systems that resist thickening at scale.
Lumson's Lombardi Deal Buys Italian Packaging Maker Its First Factories Abroad
Lumson bought Lombardi's US and Asia packaging units, giving the Italian skincare-packaging maker its first factories in North America and China/Korea, backed by a bank pool and state export lender SIMEST.
Skin Rocks Expands Scottish Spa Presence With One Spa Partnership
Caroline Hirons' skincare brand adds a second Scottish hotel-spa tie-up, launching four facials and a spa-day package at Edinburgh's Sheraton Grand this October.
Chanel, YSL and Prada Are Betting Flankers Can Recruit Fragrance-Literate Gen Z
Three luxury houses are launching flanker scents this year, but the format's success now depends on execution rather than the mere existence of a new bottle.
England's Cosmetic Injectables Complaints Pile Up While a 2022 Licensing Law Sits Unused
FOI data shows 1,700+ UK complaints over fillers, Botox and BBLs since 2021, but the detailed London-borough figures reveal patchy council enforcement and a licensing law still unused four years on.
Caudalie Group Buys Majority Stake in Talm, Its First Acquisition Ever
The French skincare group, backed by founders Mathilde and Bertrand Thomas, converts a 2022 minority investment into full control of maternity brand Talm.
Arizona's L'Oréal Suit Takes a Faster Legal Route Than the Federal Cancer Litigation
Arizona's AG is suing L'Oréal under a consumer-fraud law, not personal-injury rules, a lower legal bar that could outpace the 11,800-case federal MDL and the FDA's five-times-delayed formaldehyde ban.
Loose Setting Powder Is Back, Reengineered to Look Like Skin
Charlotte Tilbury, Dior and Too Faced are relaunching loose setting powder as a skincare-grade, blur-not-bake product, and Puig's earnings show the bet is paying off.
MPs to examine why England's cosmetic procedure licensing scheme keeps stalling
MPs are questioning ministers over years of delay in licensing non-surgical treatments like fillers and Botox, as a second promised reform, a ban on liquid BBLs, also misses its deadline.
LYMA Wants Its P.O.W.E.R. Index to Become Wellness's Evidence Standard. It Has No Referee.
LYMA is asking the wellness industry to adopt its five-part P.O.W.E.R. Index as a shared evidence standard, but has no audit mechanism and its own ASA claim violations.
Back-to-School Displays Are Becoming a Skincare Battleground
Retailers are folding skin-barrier creams and serums into back-to-school shopping trips, turning a seasonal supply run into a new front in the fight for tween beauty spend.
Rising INCI scrutiny leaves consumers short on ingredient context
Eastman says ingredient-scanning apps give shoppers names without meaning, but the INCI list those apps read is itself being rewritten by EU and US regulators on separate, colliding timelines.
Duty Free Global Beauty Bets on Bundled K-Beauty to Crack Travel Retail Shelves
Irish distributor Duty Free Global Beauty is bundling seven K-beauty brands, from Beauty of Joseon to Holika Holika, into one portfolio for airport, airline and cruise retail.
Wella Files for IPO as KKR Keeps a Stake in the Outcome
Wella's IPO filing shows $2.9B in fiscal 2026 sales, up 9.2%, and a swing to $62M net income, with KKR both the seller and an underwriter of the deal.
Vanita Parti talks Blink Brow Bar's rise, just as the brand quietly renames itself
Blink Brow Bar founder Vanita Parti details two decades of growth in a new interview, but the bigger news is what it doesn't mention: her company has quietly rebranded as BBB London.
A Body-Care Butter That Isn't for Sale Shows How Biotech Actives Move Between Categories
Core Biogenesis and distributor Faravelli unveiled a body-care demo formula built on their growth-factor actives, the third entry in a "Longevity Concepts" showcase that has already stretched from face serums into lip and eye color.
Baldness Drugs Are Wall Street's Next Goldmine
Wall Street is pricing hair-loss drugmakers like the next GLP-1, with Veradermics up nearly 500% since its February IPO and Lilly backing Absci's antibody bet.
Lumson Lands the Packaging Job Behind Lancôme's New Longevity Cream
Lancôme tapped Italian manufacturer Lumson to build the bespoke glass jar for Absolue Longevity MD, its new dermatologist-launched, $155-$175 anti-aging cream.
Saanroo's 15.5% Gray-Hair Result Shows Where the Ingredient Race Is Headed
Saanroo reports a 15.5% drop in gray hair density after 12 weeks of a serum built on its ingredient platform, joining Just For Men and Chemyunion in a new race to sell pigment reversal, not just coverage.
Behind Ulta's Beat-and-Raise, a Retail Distribution Reshuffle
Ulta Beauty's Q2 beat-and-raise landed the same month its Target shop-in-shop wound down, replaced by a smaller PacSun capsule deal as Sephora's Kohl's footprint keeps growing.
Target's Beauty Studio Isn't Just a Launch, It's a Divorce From Ulta
Target Beauty Studio launches Sept. 10 in 600+ stores, replacing Ulta Beauty at Target with a fully Target-curated lineup of 1,600+ products from 90 brands.
Natura's Q2 profit craters as a software migration undercuts its Brazil turnaround
Natura &Co's net profit sank to 35 million reais in the second quarter, a roughly 92% drop, as an SAP system migration triggered stockouts and Brazil revenue fell nearly 15% even while the company's Spanish-speaking Latin American markets grew.
Selkie secures four Dragons in £40,000 investment deal
Amersham chemist Cicely Coops asked for £40,000 for 12.5% of refillable haircare brand Selkie. All four Dragons invested, taking 20% between them.
Beauty Forum's Skin-Type Lesson Traces to a 1910 Marketing Category, Not a Clinical One
Beauty Forum Deutschland's new training column tells licensed German estheticians that skin type is genetically fixed, using a four-category system that traces to a 1910 sales classification by Helena Rubinstein rather than clinical research. Dermatology literature as recent as 2024 and 2025 still calls precise skin-type classification poorly characterized, with at least 17 competing instruments in clinical use and none adopted as the professional standard the column presents.
Anton Paar's 'Personal Care' Workshop Is a Rebadged Stop on a Recurring Circuit
Anton Paar UK's free personal care measurement workshop on 21 October 2026 is at least the fourth near-identical one-day event the instrument maker has run from the same Luton address since mid-2025, with only the industry label changed each time.
Society Management's College Sports Push Meets a Deal-Rejecting Clearinghouse
The Society Management's new alliance with Canopy Talent to broker college athlete brand deals will route every contract through a Deloitte-run NIL clearinghouse that has rejected roughly 90 million dollars in deals over the past year, a review Society's existing pro athlete clients never face.
Climatic's 55% Mucus-Clearance Claim Is a Sheep Result
Climatic's 55% mucus-clearance figure comes from an induced impairment model in sheep, not a human trial. Its published human evidence is a four-athlete uncontrolled case series, while a larger randomized study is registered but has posted no results.
JD.com Cites K-Beauty Demand, Then Signs an Eyewear Brand
JD Group's vice chairman framed his company's new Korean purchasing subsidiary as a bet on rising K-beauty demand, but the only contract disclosed from the launch event went to an eyewear brand, and Korea's cosmetics exports to China fell 5.1 percent in the same half.
AMUSE Is the Only Growth Shinsegae International's Cosmetics Unit Has Left
AMUSE's new Bangkok stores are opening just as parent Shinsegae International posts a quarterly operating loss and its cosmetics division shrinks once AMUSE is stripped out, leaving one acquired brand to carry both the unit's growth and a 2028 revenue target it is not yet on pace to hit.
Astaxanthin Comes From a Tank. Fucoidan Still Comes From the Sea.
Marine skincare's sustainability story rests on cultivated "blue biotechnology," but that describes only one of the category's flagship actives: astaxanthin comes from closed photobioreactors, while the world's leading fucoidan supplier still wild-harvests seaweed from Tasmania, where the species is officially listed as an invasive marine pest.
Behind FROM:CELLA's Myeongdong Listing, a Pharmacy Chain's Rapid Sprint
FROM:CELLA's addition to a fourth Optima Wellness Museum store is a minor brand footnote; the notable number is how fast the host chain itself has grown, from one Gangnam pharmacy in September 2025 to at least nine locations across Korea within eleven months.
SONOKO's Ginza Fair Marks a Pivot From Win-Back to New Customers
SONOKO's Philippine-themed cafe fair in Ginza, run with the Philippine Embassy and timed to the 70th anniversary of Japan-Philippines diplomatic relations, is framed by its president as a bid for customers the mail-order beauty company does not have yet. That marks a break from the lapsed-customer reactivation strategy that pulled the company out of a post-founder-death decline.
Urban Outfitters Turns a Four-Year Campus Program Into One Commercial
Urban Outfitters' first dedicated back-to-campus commercial centralizes a student-marketing system that predates the film by four years. The new element is a reusable cross-channel creative asset, not a larger disclosed creator network or a new campus strategy.
Quality First Calls Its New Mask Line the Brand's Highest Peak. It Said That Twice Before.
Quality First's press release for its new Derma Laser PRO masks calls the line the brand's highest peak in history, a claim its own footnote says is measured only against its earlier products. It is at least the third time since November 2023 that the company has given a new Derma Laser launch that same superlative, each one self-assessed rather than benchmarked against a rival or an outside standard.
Hims & Hers Grew 38%. It Also Booked $62.5 Million in FTC-Linked Charges.
Hims & Hers grew Q2 revenue 38 percent to $753.2 million and raised full-year guidance, but the same release shows a swing to an $86.3 million net loss, driven mainly by $62.5 million in legal accruals its CFO tied to the FTC's late-July privacy and billing lawsuit.
Dries Van Noten Got a Hand Cream Line. Its Founder Got a Foundation Grant.
In April 2026, Puig extended the Dries Van Noten trademark into hand and body care at Byredo-level prices while separately signing a three-year funding deal with founder Dries Van Noten's independent nonprofit foundation, two moves that reveal how the group is managing the brand's value since his 2024 exit from the runway.
Natura's Brazil Miss Traces to an ERP Rollout, Not a Demand Slump
Natura's steep Brazil revenue decline in the second quarter of 2026 traces to a stock shortage the company caused itself during a SAP S/4 system rollout, not primarily to the weak consumer demand its own results language emphasized.
Vital Beautie's PDRN Supplement Launches Into a Regulatory Gap
Amorepacific's Vital Beautie has launched an oral PDRN and collagen supplement, but PDRN itself carries no health-functional-food recognition from Korea's food and drug regulator, unlike the collagen it is paired with, even as regulator advertising violations tied to PDRN have climbed sharply since 2023.
Companies
View allCaudalie Group Buys Majority Stake in Talm, Its First Acquisition Ever
The French skincare group, backed by founders Mathilde and Bertrand Thomas, converts a 2022 minority investment into full control of maternity brand Talm.
Wella Files for IPO as KKR Keeps a Stake in the Outcome
Wella's IPO filing shows $2.9B in fiscal 2026 sales, up 9.2%, and a swing to $62M net income, with KKR both the seller and an underwriter of the deal.
Baldness Drugs Are Wall Street's Next Goldmine
Wall Street is pricing hair-loss drugmakers like the next GLP-1, with Veradermics up nearly 500% since its February IPO and Lilly backing Absci's antibody bet.
Natura's Q2 profit craters as a software migration undercuts its Brazil turnaround
Natura &Co's net profit sank to 35 million reais in the second quarter, a roughly 92% drop, as an SAP system migration triggered stockouts and Brazil revenue fell nearly 15% even while the company's Spanish-speaking Latin American markets grew.
Retail
View allSkin Rocks Expands Scottish Spa Presence With One Spa Partnership
Caroline Hirons' skincare brand adds a second Scottish hotel-spa tie-up, launching four facials and a spa-day package at Edinburgh's Sheraton Grand this October.
Back-to-School Displays Are Becoming a Skincare Battleground
Retailers are folding skin-barrier creams and serums into back-to-school shopping trips, turning a seasonal supply run into a new front in the fight for tween beauty spend.
Duty Free Global Beauty Bets on Bundled K-Beauty to Crack Travel Retail Shelves
Irish distributor Duty Free Global Beauty is bundling seven K-beauty brands, from Beauty of Joseon to Holika Holika, into one portfolio for airport, airline and cruise retail.
Behind Ulta's Beat-and-Raise, a Retail Distribution Reshuffle
Ulta Beauty's Q2 beat-and-raise landed the same month its Target shop-in-shop wound down, replaced by a smaller PacSun capsule deal as Sephora's Kohl's footprint keeps growing.
Products
View allChanel, YSL and Prada Are Betting Flankers Can Recruit Fragrance-Literate Gen Z
Three luxury houses are launching flanker scents this year, but the format's success now depends on execution rather than the mere existence of a new bottle.
Loose Setting Powder Is Back, Reengineered to Look Like Skin
Charlotte Tilbury, Dior and Too Faced are relaunching loose setting powder as a skincare-grade, blur-not-bake product, and Puig's earnings show the bet is paying off.
LYMA Wants Its P.O.W.E.R. Index to Become Wellness's Evidence Standard. It Has No Referee.
LYMA is asking the wellness industry to adopt its five-part P.O.W.E.R. Index as a shared evidence standard, but has no audit mechanism and its own ASA claim violations.
A Body-Care Butter That Isn't for Sale Shows How Biotech Actives Move Between Categories
Core Biogenesis and distributor Faravelli unveiled a body-care demo formula built on their growth-factor actives, the third entry in a "Longevity Concepts" showcase that has already stretched from face serums into lip and eye color.
Operations
View allLubrizol's New Thickener Tackles the Hardest Problem in Sulfate-Free Formulation
Glucamate Evolve is built to solve a persistent manufacturing headache: sulfate-free surfactant systems that resist thickening at scale.
Lumson's Lombardi Deal Buys Italian Packaging Maker Its First Factories Abroad
Lumson bought Lombardi's US and Asia packaging units, giving the Italian skincare-packaging maker its first factories in North America and China/Korea, backed by a bank pool and state export lender SIMEST.
Lumson Lands the Packaging Job Behind Lancôme's New Longevity Cream
Lancôme tapped Italian manufacturer Lumson to build the bespoke glass jar for Absolue Longevity MD, its new dermatologist-launched, $155-$175 anti-aging cream.
Anton Paar's 'Personal Care' Workshop Is a Rebadged Stop on a Recurring Circuit
Anton Paar UK's free personal care measurement workshop on 21 October 2026 is at least the fourth near-identical one-day event the instrument maker has run from the same Luton address since mid-2025, with only the industry label changed each time.
Regulation
View allEngland's Cosmetic Injectables Complaints Pile Up While a 2022 Licensing Law Sits Unused
FOI data shows 1,700+ UK complaints over fillers, Botox and BBLs since 2021, but the detailed London-borough figures reveal patchy council enforcement and a licensing law still unused four years on.
Arizona's L'Oréal Suit Takes a Faster Legal Route Than the Federal Cancer Litigation
Arizona's AG is suing L'Oréal under a consumer-fraud law, not personal-injury rules, a lower legal bar that could outpace the 11,800-case federal MDL and the FDA's five-times-delayed formaldehyde ban.
MPs to examine why England's cosmetic procedure licensing scheme keeps stalling
MPs are questioning ministers over years of delay in licensing non-surgical treatments like fillers and Botox, as a second promised reform, a ban on liquid BBLs, also misses its deadline.
Rising INCI scrutiny leaves consumers short on ingredient context
Eastman says ingredient-scanning apps give shoppers names without meaning, but the INCI list those apps read is itself being rewritten by EU and US regulators on separate, colliding timelines.